Optimal measurement technology – 

uncompromising quality

VEGA - a world class measurement technology provider of level and pressure equipments now completes its measurement portfolio for pharmaceuticals production with two new compact instrument series. VEGABAR and VEGAPOINT proves that automation can be simple and highly efficient without compromising on reliability, hygiene and accuracy. 

VEGABAR 38 is a universal pressure transmitter with ceramic measuring cell for measuring gases, vapours and liquids. The optional universal connection for hygienic adapters ensures reduced installation effort and leaner stock keeping. The sensor has a display with on-site operation and coloured 360° switching status indication.

  • High plant availability through maximum overload and vacuum resistance of the ceramic measuring cell
  • Coloured 360° switching status display, display and on-site operation with VDMA menu structure
  • Easy integration into control systems through IO-Link communication

www.vega.com

VEGAPOINT 21 is a low-cost limit switch for the detection of water-based liquids. The optional universal connection for hygiene adapters ensures reduced installation effort and leaner stock keeping and perfectly meets the requirements for hygienic processes in the food, beverage and pharmaceutical industries. It can be used without adjustment in the application. With IO-Link, it offers continuous digital data transmission.

  • Coloured 360° switching status display, adjustable
  • Easy integration into control systems through IO-Link communication
  • Low-cost limit switch with smallest installation dimensions

No incompatibilities

  • VEGA sensors have been specially developed for the needs of the pharmaceutical industry, which are fulfilled by securely protected sealing, all-metal housings and wetted parts with a surface finish as fine as 0.3 µm RA.

Good manufacturing practice

  • Continuous monitoring of all production processes as well as routine inspection and testing of our sensors make us a reliable partner in adhering to good manufacturing practice. The basis for this is our quality management in compliance with ISO 9001 and our environmental management program based on ISO 14001.

Easy cleaning – reliable processes

  • To help ensure hygienic and sterile drug production processes, VEGA offers materials specially tailored to the strict requirements of the pharmaceutical industry – with all necessary approvals and material properties.

VEGA Australia Pty Ltd
Phone: +61 2 95426662
Email: info.au@vega.com

www.vega.com

Go to article: Home | The logistics of delivering a global vaccineGo to article: In this issueGo to article: ContentsGo to article: MimotopesGo to article: SHL MedicalGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Solvias Company Insight Go to article: SolviasGo to article: HOF Sonderanlagenbau Company Insight Go to article: HOF SonderanlagenbauGo to article: SwiftpakGo to article: CommentGo to article: Long HCC pipeline marks change for a previously stagnant marketGo to article: Pfizer and BioNTech’s Covid-19 vaccine candidate shows 90% efficacyGo to article: Blockchain-enabled hospital can provide real-world dataGo to article: The increasing influence of industry sponsors along the pandemic timelineGo to article: Digitalisation in pharmaceutical manufacturingGo to article: VEGA AustraliaGo to article: KugelmeiersGo to article: Unither PharmaceuticalsGo to article: In DepthGo to article: Special delivery: the logistics of curing Covid-19 Go to article: Will there ever be an HIV vaccine?Go to article: Predicting Covid-19 vaccine approvals with OpylGo to article: Unequal access: understanding cancer treatment disparity in EuropeGo to article: ‘Trustpilot’ for medicines: can DrugsDiscovered help pharma be patient centric?Go to article: Q&A: investing in innovative biotechs with Novo VenturesGo to article: Gold standard: why are Phase III trials so critical?Go to article: Brewprint: using yeast to make plant-based drugsGo to article: Air FranceGo to article: Zenatek Company Insight Go to article: In DataGo to article: Inside the dealGo to article: Deals analysisGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next issue